216 related articles for article (PubMed ID: 30837539)
1. Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
Song H; Lim Y; Im H; Bae JM; Kang GH; Ahn J; Baek D; Kim TY; Yoon SS; Koh Y
Sci Rep; 2019 Mar; 9(1):3465. PubMed ID: 30837539
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
Borozan I; Zapatka M; Frappier L; Ferretti V
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
4. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic Role of Epstein-Barr Virus in Lung Cancers.
Becnel D; Abdelghani R; Nanbo A; Avilala J; Kahn J; Li L; Lin Z
Viruses; 2021 May; 13(5):. PubMed ID: 34064727
[TBL] [Abstract][Full Text] [Related]
6. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.
Lee J; Kosowicz JG; Hayward SD; Desai P; Stone J; Lee JM; Liu JO; Ambinder RF
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341058
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.
Xu M; Zhang WL; Zhu Q; Zhang S; Yao YY; Xiang T; Feng QS; Zhang Z; Peng RJ; Jia WH; He GP; Feng L; Zeng ZL; Luo B; Xu RH; Zeng MS; Zhao WL; Chen SJ; Zeng YX; Jiao Y
Theranostics; 2019; 9(4):1115-1124. PubMed ID: 30867819
[No Abstract] [Full Text] [Related]
9. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
[TBL] [Abstract][Full Text] [Related]
10. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
Worth AJ; Houldcroft CJ; Booth C
Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
[TBL] [Abstract][Full Text] [Related]
11. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.
Gulley ML
Exp Mol Med; 2015 Jan; 47(1):e134. PubMed ID: 25613731
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in cutaneous pathology.
Fernandez-Flores A
Am J Dermatopathol; 2013 Dec; 35(8):763-86. PubMed ID: 24257189
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus strain variation and cancer.
Kanda T; Yajima M; Ikuta K
Cancer Sci; 2019 Apr; 110(4):1132-1139. PubMed ID: 30697862
[TBL] [Abstract][Full Text] [Related]
14. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes.
Murata T; Okuno Y; Sato Y; Watanabe T; Kimura H
Rev Med Virol; 2020 Mar; 30(2):e2095. PubMed ID: 31845495
[TBL] [Abstract][Full Text] [Related]
16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
17. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction.
Auburn H; Zuckerman M; Smith M
J Med Microbiol; 2016 Nov; 65(11):1243-1252. PubMed ID: 27625030
[TBL] [Abstract][Full Text] [Related]
19. Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.
Camargo MC; Bowlby R; Chu A; Pedamallu CS; Thorsson V; Elmore S; Mungall AJ; Bass AJ; Gulley ML; Rabkin CS
Gastric Cancer; 2016 Apr; 19(2):676-681. PubMed ID: 26095338
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
